Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PSNL - Personalis Moderna sign agreement to use NeXT platform for mRNA cancer vaccine trials

PSNL - Personalis Moderna sign agreement to use NeXT platform for mRNA cancer vaccine trials

Personalis Inc.
  • Personalis ( NASDAQ: PSNL ) and Moderna ( NASDAQ: MRNA ) said they had signed a new agreement to continue using the PSNL's NeXT Platform as part of upcoming clinical studies testing cancer vaccine mRNA-4157/V940, jointly developed by Moderna and Merck ( MRK ).
  • The platform, which was also used in the vaccine candidate’s Phase 2b study , will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations.
  • ( PSNL ) is trading ~8% higher .

For further details see:

Personalis Moderna sign agreement to use NeXT platform for mRNA cancer vaccine trials
Stock Information
Company Name: Personalis Inc.
Stock Symbol: PSNL
Market: NASDAQ
Website: personalis.com
Menu
PSNL PSNL Quote PSNL Short PSNL News PSNL Articles PSNL Message Board
Get PSNL Alerts

News, Short Squeeze, Breakout and More Instantly...